Latest news

Nanologica’s Chief Financial Officer Eva Osterman has decided to leave the company. Eva will remain in the Group until 31 August 2026 to ensure a smooth handover and support the recruitment of her successor. The recruitment process has begun. “Since she started in 2017, Eva has had a central role in the company and been a big part of shaping the Nanologica we are today,” says Andreas Bhagwani, CEO of Nanologica AB. “As CFO, she

Nanologica AB (publ) today May 21, 2026 held its Annual General Meeting in Stockholm, at which the following resolutions were adopted.   Adoption of the income statement and balance sheet, disposition of result The Annual General Meeting adopted the income statement and balance sheet for the company and the group in accordance with the presented accounting documents and resolved, in accordance with the board’s proposal, that the accumulated loss of SEK -50,180,846 shall be carried

FINANCIAL SUMMARY Net sales for the first quarter amounted to SEK 21,456 thousand (10,751). Operating profit for the quarter amounted to SEK 66,484 thousand (-9,241). Operating profit is affected by the fact that the acquisition of Syntagon is recorded as an operating income of SEK 78 876 thousand during the period. Profit before tax for the quarter amounted to SEK 65,186 thousand (-10,171) Earnings per share before and after dilution were SEK 0.72 (-0.14) for the